FundedIQ

Recently Funded Biotechnology Startups in Cambridge

Updated Sep 2026

FundedIQ tracks 239 funded Biotechnology startups in Cambridge, with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology startup funding landscape in Cambridge, along with the 100 most recently funded Biotechnology startups in Cambridge.

Biotechnology startups in Cambridge closed 129 funding rounds over the last 24 months, 70 of them in the last 12 months, and raised $9.7B in disclosed capital. The median disclosed round is $40M, with the middle half of rounds falling between $8.4M and $115M.

Institutional capital dominates this sector. Frequent appearances by Flagship Pioneering and Third Rock Ventures indicate a preference for platform technologies over single assets. These firms favor high risk and deep science. Approaching these companies means engaging with professionalized management teams backed by specialized venture capital rather than generalist funds.

Biotechnology funded startup statistics in Cambridge

Funded Biotechnology startups in Cambridge
239
tracked in the database
Funding rounds, last 12 months
70
129 over 24 months
Disclosed capital raised, 24 months
$9.7B
117 of 129 rounds disclosed an amount
Median round size
$40M
middle half $8.4M to $115M

Most recent funding round on record: Aug 2026.

100 most recently funded Biotechnology startups in Cambridge

100 of 239

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

L
Cambridge, United States · Biotechnology
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of…
Series E ·
$188M
M
Cambridge, United States · Biotechnology
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential…
Series Unknown ·
Undisclosed
F
Cambridge, United States · Biotechnology
Flare Therapeutics is a biotech firm that is venturing into a new therapeutic domain by taking a unique…
Series C ·
$85M
D
Cambridge, United States · Biotechnology
Decoy Therapeutics is a preclinical stage biotech company building a pandemic preparedness drug development…
Series Unknown ·
$3.5M
T
Cambridge, United States · Biotechnology
Seed ·
$14M
D
Cambridge, United States · Biotechnology
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's…
Series Unknown ·
$200M
P
Cambridge, United States · Biotechnology
Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing…
Series Unknown ·
$75M
H
Harness Therapeutics
Cambridge, United Kingdom · Biotechnology
Harness Therapeutics is a private biotechnology company focused on the development of a novel class of…
Series Unknown ·
Undisclosed
T
Cambridge, United States · Biotechnology
Tango Therapeutics operator of a biotechnology company created to discover novel drug targets and deliver the…
Series Unknown ·
$600M
C
Cambridge, United States · Biotechnology
Founded by pioneering executives and scientists in RNAi, City Therapeutics is advancing next-generation…
Series B ·
$100M
L
Cambridge, United States · Biotechnology
Lysoway Therapeutics has developed technological methods to screen and develop potent modulators of lysosomal…
Series Unknown ·
$3.4M
Q
Cambridge, United States · Biotechnology
Q32 Bio is a biotechnology company focused on creating treatments for individuals suffering from severe…
Series Unknown ·
$55M
E
Cambridge, United States · Biotechnology
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. The…
Series Unknown ·
$125M
R
Cambridge, United States · Biotechnology
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational…
Series Unknown ·
$275M
T
Tevard Biosciences
Cambridge, United States · Biotechnology
Tevard Biosciences provides treatments and durable cures for many types of critical and rare genetic diseases…
Series Unknown ·
Undisclosed
C
Cambridge, United States · Biotechnology
CREATE Medicines is a clinical-stage biotechnology company focused on developing RNA-based immunotherapies…
Series B ·
$122M
O
Cambridge, United States · Biotechnology
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation…
Series Unknown ·
$25M
C
Cambridge, United Kingdom · Biotechnology
Inobrodib is a capsule taken orally and is the first small molecule drug in clinical trials that targets the…
Series D ·
$220M
A
Cambridge, United States · Biotechnology
Aura Biosciences is a biotech company in the clinical stage that is working on developing a type of therapy…
Series Unknown ·
$299M
C
Cambridge, United States · Biotechnology
Cue Biopharma is a company that specializes in immunotherapy and is creating biologics that can selectively…
Series Unknown ·
$30M
A
Cambridge, United States · Biotechnology
Series A ·
$55M
I
Cambridge, United States · Biotechnology
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can…
Series Unknown ·
$180M
S
Cambridge, United Kingdom · Biotechnology
STORM Therapeutics is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes…
Series C ·
$56M
L
Cambridge, United Kingdom · Biotechnology
Lightcast utilizes a microfluidic system to make progress in unconventional medical techniques, novel…
Series Unknown ·
$27M
D
Cambridge, United States · Biotechnology
Deck Bio develops multi-target T cell engager immunotherapies for solid tumors.
Seed ·
$3.1M
K
Cambridge, United States · Biotechnology
Kytopen develops a cell therapy platform that allows for the non-viral delivery of molecules into immune…
Series B ·
Undisclosed
S
Cambridge, United States · Biotechnology
Stipple Bio is a biotech company that focuses on advancing cellular profiling and target discovery using…
Series A ·
$100M
S
Cambridge, United Kingdom · Biotechnology
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the…
Series Unknown ·
$3.8M
V
Cambridge, United States · Biotechnology
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for…
Series Unknown ·
$75M
I
Cambridge, United Kingdom · Biotechnology
Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic…
Series A ·
$87M
T
Cambridge, United States · Biotechnology
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology…
Series Unknown ·
Undisclosed
M
Cambridge, United Kingdom · Biotechnology
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast…
Series Unknown ·
$40M
E
Cambridge, United States · Biotechnology
Elicio is dedicated to re-engineering the body's immunological response to cancer in order to improve the…
Series Unknown ·
$100M
V
Cambridge, United States · Biotechnology
Vima Therapeutics operates as a biotechnology company.Vima Therapeutics creates a new era in treatments for…
Series A ·
$40M
C
Cambridge, United States · Biotechnology
We are using autophagy, a normal cellular mechanism, to create potent new medications for a variety of…
Series Unknown ·
$7.6M
K
Cambridge, United States · Biotechnology
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to…
Series Unknown ·
$85M
A
Cambridge, United States · Biotechnology
Atavistik Bio is a biotechnology company that specializes in the discovery and development of precision…
Series B ·
$40M
C
Cambridge, United States · Biotechnology
Cognito Therapeutics is a company that specializes in neurotechnology and is currently at the clinical stage.…
Series C ·
$105M
G
Cambridge, United States · Biotechnology
GenFlow Biosciences is a synthetic biology corporation that creates gene therapies to delay or stop the aging…
Series Unknown ·
$1.1M
B
Cambridge, United States · Biotechnology
Bicara Therapeutics, a company owned entirely by Biocon and located in Boston, USA, is currently working on a…
Series Unknown ·
$150M
S
Cambridge, United Kingdom · Biotechnology
Sparxell creates the next generation of colors and effects.
Seed ·
$5.0M
P
Cambridge, United States · Biotechnology
PAQ Therapeutics is a biotechnology company that is at the forefront of developing a different method to…
Series B ·
$38M
A
Cambridge, United States · Biotechnology
Axol specialize in human cell culture. Axol Bioscience sells live human cell cultures and provides services…
Series Unknown ·
$2.8M
N
Cambridge, United Kingdom · Biotechnology
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing…
Series C ·
$12M
B
Cambridge, United Kingdom · Biotechnology
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.…
Series C ·
$50M
N
Cambridge, United States · Biotechnology
Nocion Therapeutics creates innovative pharmaceuticals designed to address conditions related to neurogenic…
Series B ·
$23M
S
Cambridge, United States · Biotechnology
STRM.BIO is a biotech firm that utilizes extracellular vesicles as a means of delivering gene therapy in a…
Seed ·
$8.0M
P
Cambridge, United States · Biotechnology
Praxis Precision Medicines is a company in the biopharmaceutical industry that focuses on developing…
Series Unknown ·
$575M
M
Cambridge, United States · Biotechnology
Mediar is a biotech firm in the pre-clinical phase aiming to create remedies for the cure of fibrosis. These…
Series Unknown ·
$38M
F
Cambridge, United States · Biotechnology
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare…
Series Unknown ·
$175M
K
Cambridge, United States · Biotechnology
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.…
Series Unknown ·
$602M
S
Cambridge, United States · Biotechnology
Solarea Bio is a biotech company focused on developing microbial therapeutics to treat chronic inflammatory…
Venture - Series Unknown ·
$9.9M
A
Cambridge, United Kingdom · Biotechnology
Artios is an independent DNA Damage Response (DDR) company focused on developing first-in-class treatments…
Series D ·
$115M
P
Cambridge, United Kingdom · Biotechnology
PACT creates stylish products made in harmony with the environment by developing innovative, eco-friendly…
Series A ·
$21M
X
Cambridge, United States · Biotechnology
Leveraging our unparalleled expertise in diseases of the immune system and CXCR4 biology, we aim to bring…
Series Unknown ·
$155M
M
Cambridge, United States · Biotechnology
Minerva Neurosciences is a company in the clinical stage of drug development that specializes in creating and…
Series Unknown ·
$80M
M
Cambridge, United Kingdom · Biotechnology
Mission Therapeutics is a drug development company targeting the ubiquitin pathway for the treatment of…
Venture - Series Unknown ·
$13M
E
Eikonizo Therapeutics
Cambridge, United States · Biotechnology
Eikonizo is developing life-changing treatments by producing brain-penetrant small compounds and utilizing in…
Series Unknown ·
Undisclosed
K
Cambridge, United States · Biotechnology
Kernal makes mRNA treatments to fix sicknesses like COVID and disease. Our mRNA treatments teach explicit…
Series Unknown ·
$48M
N
Cambridge, United Kingdom · Biotechnology
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore…
Series B ·
$68M
I
Cambridge, United States · Biotechnology
Immuneering is a biopharmaceutical company that uses its expertise in translational bioinformatics to enhance…
Series Unknown ·
$25M
L
Lura Health
Cambridge, United States · Biotechnology
Lura Health has developed the first-ever continuous health monitoring platform that does not require invasive…
Series Unknown ·
Undisclosed
S
Cambridge, United States · Biotechnology
Strand Therapeutics is a company that uses a biotechnology platform to develop gene therapies with the help…
Series B ·
$153M
A
Cambridge, United States · Biotechnology
ARTBIO is a company in the clinical stage of development that specializes in radiopharmaceutical…
Series B ·
$132M
P
Cambridge, United States · Biotechnology
Prime Medicine specializes in creating gene editing treatments using Prime Editing technology, which allows…
Series Unknown ·
$24M
B
Cambridge, United Kingdom · Biotechnology
Broken String Biosciences is working on creating a set of new sequencing tools that can analyze genome…
Series Unknown ·
Undisclosed
C
Cambridge, United States · Biotechnology
Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug…
Series Unknown ·
$7.0M
O
Cambridge, United Kingdom · Biotechnology
OutSee develops advanced computational techniques for genomics in order to identify potential therapeutic…
Seed ·
$2.4M
C
Cambridge, United States · Biotechnology
Pertinent Biosciences utilizes restrictive T-cell designing innovation in blend with growth focusing on…
Series Unknown ·
$50M
T
Cambridge, United Kingdom · Biotechnology
Tagomics revolutionizes disease diagnosis by performing in-depth profiling across multiple topics.
Series Unknown ·
$1.2M
S
Cambridge, United Kingdom · Biotechnology
Sortera Bio functions as a biotech company that is dedicated to offering groundbreaking solutions in the…
Pre-Seed ·
$10M
R
Cambridge, United States · Biotechnology
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy…
Series Unknown ·
Undisclosed
V
Cambridge, United States · Biotechnology
Vaxess Technologies is working on creating the MIMIX™ sustained release patch technology, which offers a…
Series Unknown ·
$9.0M
A
Cambridge, United States · Biotechnology
AIRNA is an innovative biotech firm focused on developing RNA editing treatments to enhance the well-being of…
Series B ·
$155M
A
Cambridge, United States · Biotechnology
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic…
Series C ·
$74M
L
Likarda
Cambridge, United States · Biotechnology
Likarda is a biotech company developing cell therapies and enabling technologies to transform the way cell…
Series Unknown ·
Undisclosed
S
Cambridge, United States · Biotechnology
Surgicure is a biotechnology start-up focused on creating advanced medical devices to enhance safety and…
Seed ·
$1.8M
G
Cambridge, United States · Biotechnology
The goal of Garuda Therapeutics is to eliminate the need for patient or donor cells in blood stem cell…
Series Unknown ·
$50M
V
Cambridge, United States · Biotechnology
VideaHealth is offers dentistAI’s software automatically detects pathologies in dental imaging, helping…
Series B ·
$40M
N
Cambridge, United States · Biotechnology
NeuroBionics is leading the way in developing advanced implanted devices that will interact with the human…
Series Unknown ·
$5.0M
L
Cambridge, United States · Biotechnology
Labviva is an online platform that connects researchers with suppliers of life science products such as…
Series B ·
$25M
A
Cambridge, United States · Biotechnology
Aviceda Therapeutics is a biotech company in the late stages of pre-clinical development that is focused on…
Series C ·
$208M
A
Cambridge, United States · Biotechnology
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Series Unknown ·
$110k
D
Cambridge, United States · Biotechnology
Dynocardia, a biomedical device development company, committed to satisfying critical unmet needs to improve…
Series Unknown ·
$1.0M
A
Cambridge, United Kingdom · Biotechnology
Abselion is the biological sensor for rapid and cost-effective detection of biological substances like…
Series A ·
$8.4M
S
Cambridge, United States · Biotechnology
Shape Biopharmaceuticals Inc. is a company based out of Cambridge, Massachusetts, United States.
Series Unknown ·
$170k
K
Cambridge, United States · Biotechnology
KalVista Pharmaceuticals is an ophthalmology company with a focus on diabetic macular edema (DME). KalVista…
Series Unknown ·
$179M
P
Cambridge, United States · Biotechnology
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or…
Seed ·
$20M
M
Cambridge, United Kingdom · Biotechnology
Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in…
Series Unknown ·
$1.3M
S
Cambridge, United States · Biotechnology
Syndevrx is a biotech company that specializes in the development of treatments for cancers sensitive to…
Series Unknown ·
$29M
P
Cambridge, United Kingdom · Biotechnology
We profile the fundamental building blocks of life, providing cross-sectional snapshots, like a CT scan for…
Series Unknown ·
$2.0M
S
Cambridge, United States · Biotechnology
Scholar Rock is a biopharmaceutical company that specializes in discovering and developing groundbreaking…
Series Unknown ·
$300M
J
Cambridge, United States · Biotechnology
Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new genetic…
Series A ·
$75M
M
Cambridge, United States · Biotechnology
Mirai Bio has created an open platform that utilizes AI to overcome the primary challenges in manufacturing…
Series A ·
$50M
E
Cambridge, United Kingdom · Biotechnology
Evoralis is a company focused on creating enzymes, specifically those that break down plastics, that…
Seed ·
$3.3M
P
Cambridge, United Kingdom · Biotechnology
PhoreMost is a drug discovery company located in Cambridge, UK that specializes in identifying new potential…
Series B ·
$12M
C
Cambridge, United Kingdom · Biotechnology
CardiaTec is a computerized biotechnology adventure consolidating the force of AI and master ability to…
Seed ·
$6.5M
C
Cambridge, United States · Biotechnology
Cellino Biotech develops intracellular delivery lasers and nanotechnology for gene editing applications. The…
Series Unknown ·
$25M
E
Cambridge, United States · Biotechnology
EnClear Therapies, a life sciences company located in Cambridge, USA, is working on developing a…
Series Unknown ·
$5.0M
M
Microbiotica
Cambridge, United Kingdom · Biotechnology
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
Series Unknown ·
Undisclosed

139 more funded startups

239 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to Aug 2024). The full 239-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 239 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Funding stages of funded Biotechnology startups in Cambridge

How the last 24 months of funding rounds for funded Biotechnology startups in Cambridge break down by stage.

Stage
Rounds, last 24 months

A further 79 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology startup funding data in Cambridge

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 239 funded Biotechnology startups in Cambridge currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (12 of 129 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology startups in Cambridge is dated Aug 2026.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology startups are there in Cambridge?

FundedIQ tracks 239 funded Biotechnology startups in Cambridge. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology startups in Cambridge raised?

Biotechnology startups in Cambridge tracked by FundedIQ have raised $9.7B in disclosed capital across 129 funding rounds over the last 24 months, including 70 rounds in the last 12 months. 117 of those 129 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

What is a typical funding round size for Biotechnology startups in Cambridge?

The median disclosed round over the last 24 months is $40M, and the middle half of rounds fall between $8.4M and $115M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology startups in Cambridge?

Series B is the most common labelled stage, with 15 rounds in the last 24 months, ahead of Seed (11) and Series A (9). A further 79 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology startup funding data in Cambridge updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology startups in Cambridge is dated Aug 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.